echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The first in China!

    The first in China!

    • Last Update: 2021-12-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Author: Sunshine

    On December 9th, the CDE official website showed that the clinical trial of Aimefel IPG7236 tablets was approved for the treatment of solid tumors


    CCR8 is a chemokine that is expressed both in most solid tumors and on tumor-associated regulatory T cells (TregII).


    Preclinical studies have shown that IPG7236 can effectively block the infiltration and expansion of Treg II in the tumor microenvironment, reduce its immunosuppressive properties, have a broad-spectrum anti-tumor effect, and is extremely safe


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.